Suppr超能文献

黑人和白人在痴呆症的患病率、风险因素和症状表现方面存在差异。

Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.

机构信息

Department of Psychology, Adler University, Chicago, Illinois, USA.

Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

出版信息

Alzheimers Dement. 2022 Aug;18(8):1461-1471. doi: 10.1002/alz.12509. Epub 2021 Dec 2.

Abstract

INTRODUCTION

Although dementia prevalence differs by race, it remains unclear whether cognition and neuropsychiatric symptom severity differ between Black and White individuals with dementia.

METHODS

Using National Alzheimer's Coordinating Center (NACC) data, we evaluated dementia prevalence in non-Hispanic Black and White participants and compared their clinicodemographic characteristics. We examined race differences in cognition, neuropsychiatric symptoms, and functional abilities in participants with dementia using multivariable linear and logistic regression models.

RESULTS

We included 5,700 Black and 31,225 White participants across 39 Alzheimer's Disease Research Centers. Of these, 1,528 (27%) Black and 11,267 (36%) White participants had dementia diagnoses. Despite having lower dementia prevalence, risk factors were more prevalent among Black participants. Black participants with dementia showed greater cognitive deficits, neuropsychiatric symptoms/severity, and functional dependence.

DISCUSSION

Despite lower dementia prevalence, Black participants with dementia had more dementia risk factors, as well as greater cognitive impairment and neuropsychiatric symptom severity than White participants.

摘要

简介

尽管痴呆症的患病率因种族而异,但黑人和白人痴呆症患者的认知和神经精神症状严重程度是否存在差异仍不清楚。

方法

我们使用国家阿尔茨海默病协调中心(NACC)的数据,评估了非西班牙裔黑人和白人参与者中的痴呆症患病率,并比较了他们的临床人口统计学特征。我们使用多变量线性和逻辑回归模型,检查了痴呆症参与者的认知、神经精神症状和功能能力方面的种族差异。

结果

我们纳入了 39 个阿尔茨海默病研究中心的 5700 名黑人参与者和 31225 名白人参与者。其中,1528 名(27%)黑人参与者和 11267 名(36%)白人参与者被诊断为痴呆症。尽管痴呆症的患病率较低,但黑人参与者的风险因素更为普遍。患有痴呆症的黑人参与者表现出更大的认知缺陷、神经精神症状/严重程度和功能依赖。

讨论

尽管痴呆症的患病率较低,但患有痴呆症的黑人参与者比白人参与者有更多的痴呆症风险因素,以及更大的认知障碍和神经精神症状严重程度。

相似文献

1
Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.
Alzheimers Dement. 2022 Aug;18(8):1461-1471. doi: 10.1002/alz.12509. Epub 2021 Dec 2.
4
Racial Differences in Clinical Presentation in Individuals Diagnosed With Frontotemporal Dementia.
JAMA Neurol. 2023 Nov 1;80(11):1191-1198. doi: 10.1001/jamaneurol.2023.3093.
5
Racial/ethnic differences in neuropsychiatric disturbances associated with incident dementia.
Alzheimers Dement (Amst). 2024 Jul 5;16(3):e12615. doi: 10.1002/dad2.12615. eCollection 2024 Jul-Sep.
7
Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease.
Dement Geriatr Cogn Disord. 2014;37(5-6):315-26. doi: 10.1159/000351009. Epub 2014 Jan 25.
10
Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.
J Alzheimers Dis. 2021;80(3):1129-1138. doi: 10.3233/JAD-201370.

引用本文的文献

1
Ethnic Differences in Dementia Diagnosis and Treatment in Israel.
J Clin Med. 2025 Aug 22;14(17):5926. doi: 10.3390/jcm14175926.
2
Cardiometabolic disorders and mild cognitive impairment in White and Black Americans.
Alzheimers Dement. 2025 Sep;21(9):e70642. doi: 10.1002/alz.70642.
4
Changes in Medicare's Chronic Condition Files and Disparities in Dementia Identification.
J Am Med Dir Assoc. 2025 Sep 3:105857. doi: 10.1016/j.jamda.2025.105857.
5
Bridging Health Disparity Gaps in Alzheimer's Disease among Marginalized Populations: Clinical Proteomics as a Case Study.
ACS Bio Med Chem Au. 2025 Jul 8;5(4):505-518. doi: 10.1021/acsbiomedchemau.5c00074. eCollection 2025 Aug 20.
6
Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry: A Randomized Clinical Trial.
JAMA Health Forum. 2025 Aug 1;6(8):e252273. doi: 10.1001/jamahealthforum.2025.2273.
7
Establishing tau-PET cut-points for cognitive diagnosis with F-PI-2620 in a multi-ethnoracial cohort.
Imaging Neurosci (Camb). 2025 Jun 16;3. doi: 10.1162/IMAG.a.41. eCollection 2025.
9
Is dolichol pathway dysfunction a significant factor in Alzheimer's disease?
Inflammopharmacology. 2025 Jul 25. doi: 10.1007/s10787-025-01868-x.

本文引用的文献

1
Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities Abound.
JAMA Netw Open. 2021 Jul 1;4(7):e2114606. doi: 10.1001/jamanetworkopen.2021.14606.
2
Perils of Race-Based Norms in Cognitive Testing: The Case of Former NFL Players.
JAMA Neurol. 2021 Apr 1;78(4):377-378. doi: 10.1001/jamaneurol.2020.4763.
4
Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review.
Alzheimers Dement (N Y). 2019 Nov 19;5:751-770. doi: 10.1016/j.trci.2019.09.018. eCollection 2019.
5
Ethnicity and risk of diagnosed dementia after stroke: a cohort study using the Clinical Practice Research Datalink.
J Epidemiol Community Health. 2020 Feb;74(2):114-119. doi: 10.1136/jech-2019-212825. Epub 2019 Nov 7.
6
Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer's Disease.
Front Pharmacol. 2019 Sep 24;10:1062. doi: 10.3389/fphar.2019.01062. eCollection 2019.
7
Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center.
Alzheimers Dement. 2019 Dec;15(12):1533-1545. doi: 10.1016/j.jalz.2019.07.015. Epub 2019 Oct 7.
8
The Impact of Unconscious Bias in Healthcare: How to Recognize and Mitigate It.
J Infect Dis. 2019 Aug 20;220(220 Suppl 2):S62-S73. doi: 10.1093/infdis/jiz214.
9
Serotonergic system, cognition, and BPSD in Alzheimer's disease.
Neurosci Lett. 2019 Jun 21;704:36-44. doi: 10.1016/j.neulet.2019.03.050. Epub 2019 Apr 1.
10
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Alzheimers Dement. 2019 Feb;15(2):292-312. doi: 10.1016/j.jalz.2018.09.009. Epub 2018 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验